Cardlytics, Inc. (NASDAQ:CDLX) CFO Sells $32,494.18 in Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CFO Alexis Desieno sold 8,854 shares of the firm’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total transaction of $32,494.18. Following the transaction, the chief financial officer now owns 121,976 shares of the company’s stock, valued at approximately $447,651.92. This trade represents a 6.77 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Alexis Desieno also recently made the following trade(s):

  • On Friday, November 15th, Alexis Desieno sold 25,118 shares of Cardlytics stock. The stock was sold at an average price of $3.43, for a total value of $86,154.74.

Cardlytics Price Performance

CDLX stock traded down $0.32 during trading on Monday, hitting $3.49. The company had a trading volume of 2,033,344 shares, compared to its average volume of 1,212,448. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. The company has a market cap of $177.37 million, a P/E ratio of -0.57 and a beta of 1.53. Cardlytics, Inc. has a fifty-two week low of $2.89 and a fifty-two week high of $20.52. The company has a fifty day moving average price of $3.93 and a two-hundred day moving average price of $4.85.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million for the quarter, compared to analysts’ expectations of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The firm’s quarterly revenue was down 15.1% compared to the same quarter last year. During the same quarter last year, the business earned ($0.26) earnings per share. Equities research analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CDLX has been the topic of several research analyst reports. Craig Hallum upgraded shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Evercore ISI initiated coverage on Cardlytics in a research report on Friday, October 11th. They issued an “in-line” rating and a $4.00 target price on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Cardlytics has an average rating of “Hold” and an average target price of $6.92.

Read Our Latest Stock Report on Cardlytics

Institutional Investors Weigh In On Cardlytics

Large investors have recently modified their holdings of the business. Atom Investors LP acquired a new stake in Cardlytics in the 3rd quarter valued at $33,000. XTX Topco Ltd acquired a new position in shares of Cardlytics in the 2nd quarter valued at approximately $107,000. SG Americas Securities LLC acquired a new stake in Cardlytics in the third quarter valued at about $45,000. Intech Investment Management LLC bought a new stake in shares of Cardlytics during the third quarter worth $47,000. Finally, Quest Partners LLC increased its position in Cardlytics by 160.4% in the 2nd quarter. Quest Partners LLC now owns 17,956 shares of the company’s stock valued at $147,000 after acquiring an additional 11,061 shares during the period. 68.10% of the stock is currently owned by institutional investors.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.